secobarbital will minimize the extent or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Carefully. Consider a rise in cannabidiol dosage (determined by scientific response and tolerability) when coadministered with a powerful CYP3A4 inducer.The effect from the resultant lessened blood levels o